Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18101772 | COMPOUNDS AND METHODS FOR TREATING CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17766189 | IMMUNOMODULATORY IMIDE DRUGS AS ZETA-CHAIN-ASSOCIATED PROTEIN KINASE 70 (ZAP70) AGONISTS AND USES THEREOF | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18755002 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | Non-Final OA | VANDERBILT UNIVERSITY |
| 18063604 | COMPOSITIONS AND METHODS FOR IMPROVED MESENCHYMAL STEM CELL THERAPY | Final Rejection | The Chinese University of Hong Kong |
| 18364200 | CHEMICAL MODIFICATION OF ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | Non-Final OA | Nautilus Subsidiary, Inc. |
| 18840040 | METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH | Non-Final OA | Yale University |
| 18816550 | PROCESSES FOR THE PREPARATION OF PHENYLTETRAHYDROFURAN COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18034965 | METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS | Final Rejection | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy